Kate O'Connell (Dublin Bay South, Fine Gael) | Oireachtas source

I know all this but my question was specific. Mr. Mulvany knows my question. When the HSE initiates somebody, a child or adult, on an expensive high-tech or orphan drug on which perhaps the sum does not add up but a decision is made to give it, has the HSE any way of pulling back from that decision if the therapy is not giving bang for buck?